Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements and cytology in pancreatic juice

Medical Molecular Morphology

Volumn 44, Issue 2, 2011, Pages 86-92

  Naito, Yoshiki ^a   Okabe, Yoshinobu ^a   Nagayama, Masakatsu ^b   Nishinakagawa, Takuya ^b   Taira, Tomoki ^c   Kawahara, Akihiko ^c   Hattori, Satoshi ^d   MacHida, Kazuyuki ^b   Ishida, Yusuke ^a   Kaji, Ryohei ^a   Mikagi, Kazuhiro ^a   Kinoshita, Hisafumi ^a   Yasumoto, Makiko ^a   Akiba, Jun ^a   Kage, Masayoshi ^c   Nakashima, Manabu ^b   Ohshima, Koichi ^a   Yano, Hirohisa ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c KURUME UNIVERSITY HOSPITAL   (Japan)

^d KURUME UNIVERSITY   (Japan)

Author keywords

CEA; Pancreatic cancer; Pancreatic cytology; Pancreatic juice; RCAS1

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS CANCER; PANCREAS JUICE; PANCREAS SURGERY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR CELL;

AGED; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CYTODIAGNOSIS; CYTOLOGICAL TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC DISEASES; PANCREATIC JUICE; PANCREATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 79960607000     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-010-0511-6     Document Type: Article

References (26)

1. J.C. Wong D.S.K. Lu 2008 Staging of pancreatic adenocarcinoma by imaging studies Clin Gastroenterol Hepatol 6 1301 1308 18948228 10.1016/j.cgh.2008.09. 014
2. K. Strobel S. Heinrich U. Bhure J. Soyka P. Veit-Haibach B.C. Pestalozzi P.A. Clavein T.F. Hany 2008 Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the respectability of pancreatic cancer J Nucl Med 49 1408 1413 18703604 10.2967/jnumed.108.051466
3. M.I. Canto M. Goggins R.H. Hruban G.M. Petersen F.M. Giardiello C. Yeo E.K. Fishman K. Brune J. Axilbund C. Griffin S. Ali J. Richman S. Jagannath S.V. Kantsevoy A.N. Kallon 2006 Screening for early pancreatic neoplasm in high-risk individuals: a prospective controlled study Clin Gastroenterol Hepatol 4 766 781 16682259 10.1016/j.cgh.2006.02.005 (Pubitemid 43825802)
4. J. Vandervoort R.M. Soetikno H. Montes D.R. Lichtenstein J. Van Dam F.W. Ruymann E.S. Cibas D.L. Carr-Locke 1999 Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct Gastrointest Endosc 49 322 327 10049415 10.1016/S0016-5107(99)70008-8 1:STN:280:DyaK1M7lvVKrsA%3D%3D (Pubitemid 29135224)
5. N. Uchida H. Kamada K. Tsutsui M. Ono Y. Aritomo T. Masaki Y. Kushida R. Haba T. Nakatsu S. Kuriyama 2007 Utility of pancreatic duct brushing for diagnosis of pancreatic carcinoma J Gastroenterol 42 657 662 17701129 10.1007/s00535-007-2071-7 (Pubitemid 47278691)
6. T. Imamura R. Takeshita R. Koyama C. Okuda K. Takeuchi M. Matsuda M. Hashimoto G. Watanabe H. Yoshida M. Imawari 2006 Effectiveness of cytodiagnosis with pancreatic duct lavage fluid for pancreatic ductal carcinoma: new sampling technique Dig Endosc 18 303 307 10.1111/j.1443-1661.2006.00661.x (Pubitemid 44341881)
7. L. Yan C. McFaul N. Howes J. Leslie G. Lancaster T. Wong J. Threadgold J. Evans I. Glimore H. Smart M. Lombard J. Neoptolemos W. Greenhalf 2005 Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk group Gastroenterology 128 2124 2130 15940643 10.1053/j.gastro.2005.03.006 1:CAS:528:DC%2BD2MXlvFKltL0%3D (Pubitemid 40824719)
8. Y. Bian H. Matsubayashi C.P. Li T. Abe M. Canto K.M. Murphy M. Goggins 2006 Detecting low-abundance p16 and p53 mutation in pancreatic juice using a novel assay: heteroduplex analysis of limiting dilution PCRs Cancer Biol Ther 5 1392 1399 17106238 10.4161/cbt.5.10.3453 1:CAS:528:DC%2BD2sXhsF2ltrs%3D (Pubitemid 44773687)
9. S.J. Myung M.H. Kim Y.S. Kim H.J. Kim E.T. Park K.S. Yoo B.C. Lim D. Wan Seo S.K. Lee Y.I. Min J.Y. Kim 2000 Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation Gastrointest Endosc 51 708 713 10840305 10.1067/mge.2000.104654 1:STN:280:DC%2BD3cvht1aktA%3D%3D (Pubitemid 30397289)
10. H. Uehara A. Nakaizumi H. Iishi A. Takenaka H. Eguchi H. Ohigashi O. Ishikawa 2008 In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases Pancreas 36 236 240 18362835 10.1097/MPA.0b013e31815bc1d6 1:CAS:528:DC%2BD1cXkvVentLw%3D (Pubitemid 351440926)
11. K. Hiraoka Y. Hida M. Miyamoto T. Oshikiri M. Suzuoki Y. Nakakubo T. Shinohara T. Itoh T. Shichinohe S. Kondo N. Kasahara H. Katoh 2002 High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker Int J Cancer 99 418 423 11992411 10.1002/ijc.10381 1:CAS:528:DC%2BD38XjsFagtbs%3D (Pubitemid 34495856)
12. T. Kaku K. Sonoda T. Kamura T. Hirakawa K. Sakai S. Amada S. Ogawa H. Kobayashi M. Nakashima T. Watanabe H. Nakano 1999 The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix Clin Cancer Res 5 1449 1453 10389931 1:STN:280:DyaK1Mzhs1OqsQ%3D%3D (Pubitemid 29282951)
13. K. Sonoda T. Kaku T. Hirakawa H. Kobayashi S. Amada K. Sakai M. Nakashima T. Watanabe H. Nakano 2000 The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium Gynecol Oncol 79 424 429 11104614 10.1006/gyno.2000.5981 1:CAS:528:DC%2BD3cXosVOmt7k%3D
14. H. Takahashi H. Iizuka M. Nakashima T. Wada K. Asano A. Ishida-Yamamoto T. Watanabe 2001 RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin J Dermatol Sci 26 140 144 11378331 10.1016/S0923-1811(00)00170-5 1:CAS:528: DC%2BD3MXjvV2kuro%3D (Pubitemid 32510722)
15. T. Suzuki S. Inoue W. Kawabata J. Akahira T. Moriya F. Tsuchiya S. Ogawa M. Marumatsu H. Sasano 2001 EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions Br J Cancer 85 1731 1737 11742495 10.1054/bjoc.2001.2176 1:CAS:528:DC%2BD38XnsVChug%3D%3D (Pubitemid 34081520)
16. M. Tsuneizumi H. Nagai H. Harada T. Kazui M. Emi 2002 A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer Ann Hum Biol 29 457 460 12160478 10.1080/03014460110087762 (Pubitemid 34842119)
17. K. Noguchi M. Enjoji M. Nakamuta M. Nakashima H. Nishi I. Choi K. Taguchi K. Kotoh M. Shimada K. Sugimachi M. Tsuneyoshi H. Nawata T. Watanabe 2001 Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma Cancer Lett 168 197 202 11403925 10.1016/S0304-3835(01)00541-9 1:CAS:528:DC%2BD3MXktlWmsLw%3D (Pubitemid 32524282)
18. T. Oshikiri Y. Hida M. Miyamoto H. Hashida K. Katoh M. Suzuoki Y. Nakakubo K. Hiraoka T. Shinohara T. Itoh S. Kondo H. Katoh 2001 RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer Br J Cancer 85 1922 1927 11747335 10.1054/bjoc.2001.2192 1:CAS:528:DC%2BD38XhsVWnu7w%3D (Pubitemid 34775330)
19. M. Kubokawa M. Nakashima T. Yao K.I. Ito N. Harada H. Nawata T. Watanabe 2001 Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer Int J Oncol 19 695 700 11562743 1:CAS:528:DC%2BD3MXnsFSmtbg%3D
20. K. Ohshima K. Muta M. Nakashima S. Haraoka T. Tutiya J. Suzumiya C. Kawasaki T. Watanabe M. Kikuchi 2001 Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion Int J Cancer 93 91 96 11391627 10.1002/ijc.1300 1:CAS:528:DC%2BD3MXksFanurY%3D (Pubitemid 32539507)
21. M. Izumi Y. Nakanishi I. Yoshino M. Nakashima T. Watanabe N. Hara 2001 Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma Cancer (Phila) 92 446 451 10.1002/1097-0142(20010715)92:2<446::AID-CNCR1341>3.0.CO;2-3 1:STN:280:DC%2BD3Mvhs12jtQ%3D%3D (Pubitemid 32664453)
22. M. Nakashima K. Sonoda T. Watanabe 1999 Inhibition of cell growth and induction of apoptotic cell death by the human tumorassociated antigen RCAS1 Nat Med 5 938 942 10426319 10.1038/11383 1:CAS:528:DyaK1MXltVyjtr4%3D (Pubitemid 29372422)
23. M. Enjoji M. Nakamuta K. Noguchi R. Sugimoto K. Kotoh H. Nawata M. Nakashima T. Watanabe 2002 RCAS1 expression in immune-mediated liver diseases J Clin Gastroenterol 34 286 287 11873118 10.1097/00004836-200203000-00023 (Pubitemid 34177391)
24. K. Yamaguchi M. Enjoji M. Nakashima M. Nakamuta T. Watanabe M. Tanaka 2005 Novel serum tumor marker, RCAS1, in pancreatic diseases World J Gastroenterol 11 5199 5202 16127752 1:CAS:528:DC%2BD2MXhtFyhsrfN (Pubitemid 41410339)
25. M. Tanaka S. Chari V. Adsay C. Fernandez-del Castillo M. Falconi M. Shimizu K. Yamaguchi K. Yamao S. Matsuno International Association of Pancreatology 2006 International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas Pancreatology 6 17 32 16327281 10.1159/000090023
26. T. Matsushima M. Nakashima K. Ohshima Y. Abe J. Nishimura H. Nawata T. Watanabe K. Muta 2001 Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells Blood 98 313 321 11435298 10.1182/blood.V98.2.313 1:CAS:528:DC%2BD3MXlt1Krtrk%3D